Tokai, Yoshitaka
Horiuchi, Yusuke
Yamamoto, Noriko
Namikawa, Ken
Yoshimizu, Shoichi
Ishiyama, Akiyoshi
Yoshio, Toshiyuki
Hirasawa, Toshiaki
Fujisaki, Junko
Article History
Received: 27 June 2023
Accepted: 28 November 2023
First Online: 4 December 2023
Declarations
:
: This study was approved by the Institutional Review Board of the Cancer Institute Hospital (approval number: 2017-1068). All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration of 1964 and later versions.Written informed consent for participating in the study was waived by the IRB of the Cancer Institute Hospital, Tokyo, due to the retrospective nature of this study.
: Not applicable.
: Y.H. has received research grants from Grant-in-Aid for Early-Career Scientists (21K15962) and the Japanese Gastric Cancer Association Research Committee, and personal fees for specific speaking and teaching commitments as honoraria from Olympus Corporation and Kaken Pharmaceutical Co., Ltd. The rest of the authors declare that they have no competing interests.